354 related articles for article (PubMed ID: 19466922)
21. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
[TBL] [Abstract][Full Text] [Related]
22. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
23. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.
Winstock AR; Lea T
Subst Use Misuse; 2010; 45(1-2):240-52. PubMed ID: 20025451
[TBL] [Abstract][Full Text] [Related]
24. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
[TBL] [Abstract][Full Text] [Related]
25. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
Harris AH; Gospodarevskaya E; Ritter AJ
Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
[TBL] [Abstract][Full Text] [Related]
26. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
27. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
28. Clinic-based treatment for opioid dependence: a qualitative inquiry.
McMurphy S; Shea J; Switzer J; Turner BJ
Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
[TBL] [Abstract][Full Text] [Related]
29. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
30. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
Doran CM; Shanahan M; Bell J; Gibson A
Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
[TBL] [Abstract][Full Text] [Related]
31. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
[TBL] [Abstract][Full Text] [Related]
32. Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.
Burns L; Randall D; Hall WD; Law M; Butler T; Bell J; Degenhardt L
Addiction; 2009 Aug; 104(8):1363-72. PubMed ID: 19549053
[TBL] [Abstract][Full Text] [Related]
33. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.
Oliva EM; Harris AH; Trafton JA; Gordon AJ
Drug Alcohol Depend; 2012 May; 122(3):241-6. PubMed ID: 22115887
[TBL] [Abstract][Full Text] [Related]
34. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
35. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
36. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
37. Using buprenorphine for outpatient opioid detoxification.
Manlandro JJ
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
[TBL] [Abstract][Full Text] [Related]
38. Opioid dependence: rationale for and efficacy of existing and new treatments.
Fiellin DA; Friedland GH; Gourevitch MN
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
40. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
Gibson AE; Degenhardt LJ
Drug Alcohol Rev; 2007 Jul; 26(4):405-10. PubMed ID: 17564876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
